FAM160A2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.327400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.730600E-01
Normal-vs-Stage2
3.098200E-01
Normal-vs-Stage3
9.664200E-01
Normal-vs-Stage4
2.515900E-02
Stage1-vs-Stage2
8.251200E-01
Stage1-vs-Stage3
3.293600E-01
Stage1-vs-Stage4
4.219600E-01
Stage2-vs-Stage3
2.704400E-01
Stage2-vs-Stage4
3.091200E-01
Stage3-vs-Stage4
1.130440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.457600E-01
Normal-vs-AfricanAmerican
2.501600E-01
Normal-vs-Asian
3.311800E-01
Caucasian-vs-AfricanAmerican
8.705800E-01
Caucasian-vs-Asian
3.248200E-01
AfricanAmerican-vs-Asian
6.969000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.077600E-01
Normal-vs-Female
3.869400E-01
Male-vs-Female
2.926800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.842800E-01
Normal-vs-Age(41-60Yrs)
2.618400E-01
Normal-vs-Age(61-80Yrs)
3.820800E-01
Normal-vs-Age(81-100Yrs)
3.608800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.789800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.591200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.343800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.511400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.183800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.841400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.029800E-01
Normal-vs-Daily Drinker
3.300800E-01
Normal-vs-Weekly Drinker
5.548200E-01
Normal-vs-Occasional Drinker
1.969840E-01
Normal-vs-Social Drinker
4.103600E-01
Non Drinker-vs-Daily Drinker
8.507200E-01
Non Drinker-vs-Weekly Drinker
6.544000E-01
Non Drinker-vs-Occasional Drinker
6.226200E-01
Non Drinker-vs-Social Drinker
5.264800E-01
Daily Drinker-vs-Weekly Drinker
7.734800E-01
Daily Drinker-vs-Occasional Drinker
5.171400E-01
Daily Drinker-vs-Social Drinker
6.485600E-01
Weekly Drinker-vs-Occasional Drinker
4.413000E-01
Weekly Drinker-vs-Social Drinker
9.357400E-01
Occasional Drinker-vs-Social Drinker
2.913800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.193700E-02
Normal-vs-Grade 2
7.242300E-03
Normal-vs-Grade 3
1.522270E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.784400E-02
Grade 1-vs-Grade 3
1.366590E-01
Grade 1-vs-Grade 4
7.193700E-02
Grade 2-vs-Grade 3
6.757400E-01
Grade 2-vs-Grade 4
7.242300E-03
Grade 3-vs-Grade 4
1.522270E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.949000E-01
Normal-vs-NonDiabetic
3.099000E-01
Diabetic-vs-NonDiabetic
5.019400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.523800E-02
Normal-vs-NoPancreatitis
4.075000E-01
Pancreatitis-vs-NoPancreatitis
2.161800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.566000E-01
Normal-vs-N1
3.541800E-01
N0-vs-N1
1.738010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.808950E-01
Normal-vs-TP53-NonMutant
5.216200E-01
TP53-Mutant-vs-TP53-NonMutant
9.416400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
